BlueSkeye AI appoints Steve Cliffe to its board of directors.
BlueSkeye has deepened the deep tech expertise on its board by appointing former CEO of Ultraleap, Steve Cliffe as a Non-Executive Director and special advisor. Steve Cliffe joins BlueSkeye as the company scales and advances its ethical AI technology, partnerships and customer portfolio.
Rebecca Ganz, Chair of BlueSkeye board and Non-Executive Director at Bolton NHS trust, said “we are really looking forward to having Steve join us. BlueSkeye has ambitious plans to apply its proprietary technology within clinical and industry contexts in pursuit of transforming lives and improving global mental health. We anticipate benefitting significantly from Steve’s broad experiences and knowledge.”
Steve brings more than two decades of executive leadership experience to BlueSkeye. In September 2021, Steve won the TechSpark LifeTime Achievement Award in recognition of his contribution to leadership of Ultraleap, the global leader in hand tracking and haptics technology. Steve was founding CEO of Ultraleap, during this time his achievements included growing the company to a global team of 170, overseeing several successful funding rounds, leading international expansion and managing acquisitions.
“It is wonderful to welcome Steve to our Board and have him support our growth and ambition”, said CEO of BlueSkeye, Professor Michel Valstar. “Steve will bring a wealth of industry experience to BlueSkeye as we focus on our long -term goal of becoming one of the most impactful companies in the social robotics and health and wellbeing sectors”.
“I am delighted to join the BlueSkeye Board and look forward to working with Michel and the BlueSkeye leadership team, and the entire board as BlueSkeye moves to an exciting new phase of growth”, Steve Cliffe said. “There has never been a more exciting or appropriate time for ethical AI and machine learning to inform the developing Social Robotics and Virtual Assistants sector and to contribute to the evolution of the delivery of healthcare. I am excited to bring my experience to transform these markets with BlueSkeye”.
As leader of Ultraleap, Steve Cliffe has overseen a number of strategic investments and acquisitions including San Francisco’s Leap Motion which significantly enhanced Ultraleap’s IP portfolio and product offering. Steve’s leadership of Ultraleap saw the company recognised as one of the 50 most innovative in the West of England and he was instrumental in securing major deals that have seen Ultraleap’s technology installed in virtual reality, augmented reality, automotive markets amongst others.
An alumnus of Nottingham University, Steve studied Electronic and Electrical Engineering and is delighted to be supporting BlueSkeye, an SME spin-out from Nottingham University. “It is good to be back in Nottingham after many years and to the commercialisation of innovative world-leading technology based on Michel’s rigorous evidence-base”.
Steve Cliffe’s appointment to BlueSkeye follows several other recent hires that have joined to support the rapid expansion and extension of the company.